Company details

About

Atherosclerosis is a chronic inflammatory disease in which the walls of the blood vessels are thickened and become less elastic. During the discovery phase of the collaboration, Dyax will utilize its proprietary antibody libraries to generate fully human monoclonal antibodies.

icon

Number of employees

1 - 10

icon

Main industry

Health Care

icon

Industry tags

icon

Founded in

2005

icon

Headquarters

Stockholm

icon

Country

Sweden

Sign up to uncover company details

5 free credit every month

Employee contacts

Name

Job Title

Email

Phone

Business Advisor

Uncover details

CEO

Uncover details

Reach Decision Makers
at Athera Biotechnologies Ab

5 Free credits every month!

Sign up now to uncover all the contact details